Norén Elisabeth, Almer Sven, Söderman Jan
Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.
Division of Medical Diagnostics, Region Jönköping County, Jönköping, Sweden.
BMC Gastroenterol. 2017 May 25;17(1):68. doi: 10.1186/s12876-017-0620-y.
Inflammatory bowel disease (IBD) is associated with increased intestinal permeability, which involves paracellular passage regulated through tight junctions (TJ). The aim of the study was to investigate single nucleotide polymorphisms (SNP) located in genes encoding interacting TJ proteins and corresponding expressions, in relation to IBD.
Allelic associations between TJ-related genes (F11R, MAGI1, MAGI2, MAGI3, PARD3, PTEN, and TJP1) and IBD, Crohn's disease (CD), or ulcerative colitis (UC) were investigated. PTPN22 was included since it's located in the same genetic region as MAGI3. Gene expression levels were investigated in relation to genotype, inflammatory status, phenotype, and medical treatment.
The two strongest allelic associations were observed between IBD and SNPs in MAGI2 (rs6962966) and MAGI3 (rs1343126). Another MAGI3 SNP marker (rs6689879) contributed to increased ileal MAGI3 expression level in non-IBD controls. Furthermore, association between inflammation and decreased expression levels of MAGI3, PTEN, and TJP1 in colonic IBD as well as UC mucosa, and between inflammation and increased expression of PTPN22 in colonic IBD mucosa, was observed.
Our findings lend support to a genetic basis for modulation of intestinal epithelial barrier in IBD, and we have identified MAGI3 as a new candidate gene for IBD.
炎症性肠病(IBD)与肠道通透性增加有关,这涉及通过紧密连接(TJ)调节的细胞旁通道。本研究的目的是调查编码相互作用的TJ蛋白的基因中的单核苷酸多态性(SNP)及其相应表达与IBD的关系。
研究了TJ相关基因(F11R、MAGI1、MAGI2、MAGI3、PARD3、PTEN和TJP1)与IBD、克罗恩病(CD)或溃疡性结肠炎(UC)之间的等位基因关联。纳入PTPN22是因为它与MAGI3位于同一基因区域。研究了基因表达水平与基因型、炎症状态、表型和药物治疗的关系。
在IBD与MAGI2(rs6962966)和MAGI3(rs1343126)的SNP之间观察到两个最强的等位基因关联。另一个MAGI3 SNP标记(rs6689879)导致非IBD对照中回肠MAGI3表达水平升高。此外,观察到炎症与结肠IBD以及UC黏膜中MAGI3、PTEN和TJP1表达水平降低之间的关联,以及炎症与结肠IBD黏膜中PTPN22表达增加之间的关联。
我们的研究结果支持IBD中肠道上皮屏障调节的遗传基础,并且我们已将MAGI3鉴定为IBD的一个新候选基因。